Connect with us

Subscribe

Subscribe

News & Views

Canada has approved a drug that has been linked to the deaths of millions of unborn babies and dozens of mothers

BY SIMONE J. SMITH

Abortion is a highly emotional subject and one that excites deeply held opinions. Equitable access to safe abortion services is first and foremost a human right, and I want to point out a keyword in the above sentence SAFE!

I was disturbed by an email forwarded to be from CitizenGo about a 19-year-old girl who died in Canada due to the abortion pill Mifegymiso (also known as RU-486).

It is safe to say that she would be alive today if Health Canada had not approved the chemical abortion pill as “SAFE” in 2015. Mifegymiso is designed to kill preborn babies, and also has known deadly risks to the mother’s life.

This 19-year-old girl died on July 4th, 2022. Her death was first reported to the Government of Canada’s public database that tracks adverse reactions to drugs. The report shows that, on July 4th, 2022, a hospital reported that a 19-year-old female used the abortion drug Mifegymiso and died of “septic shock,” a known risk of the drug.

The tragic news came as abortion activists pushed to expand the abortion drug mifepristone across the U.S. and Canada, claiming it’s “Safer than Tylenol.” In actuality, the drug has been linked to the deaths of millions of unborn babies and dozens of mothers.

This is not the first death of a woman in Canada from the abortion pill. In 2001, a 26-year-old woman died during a clinical trial of the drug, and the trials were halted as a result. Despite this, Health Canada went on to APPROVE Mifegymiso for its “SAFETY, efficacy, and quality.”

The medication started to become available to the public in January 2017. Mifepristone is an anti-hormone used to end a pregnancy. The Mifepristone and Misoprostol regimen is on the World Health Organization’s list of essential drugs. It is considered the “gold standard” for medical abortion.

Mifepristone is already available in 60 countries. Its use has been approved in France and in China since 1988 (almost 30 years ago) and the claim is that it has maintained an outstanding safety record throughout the world. In many countries, it is used safely up to 10 weeks of pregnancy and beyond. Just like surgical abortion, trained providers offer the procedure under high quality conditions, which highly diminish the risk of possible complications.

In Canada, Mifegymiso can currently be prescribed up to nine weeks gestation for on-label use. Physicians can prescribe it off-label up to 10 weeks of gestation as it has been used safely and effectively up to that gestational age and beyond.

CitizenGO feels strongly that BANNING Mifegymiso in Canada will save women’s lives and the lives of their preborn children. How many more lives will this drug claim before Health Canada decides that it is time to act? Although abortion activists claim the drug is extremely safe for women, reports of women’s deaths, data and studies show the opposite to be true. Even the Health Canada government website warns women that the abortion drug has serious risks, including death.

CitizenGO is partnering with Campaign Life Coalition (CLC) to demand that Health Canada bans Mifegymiso. They need your voice to pressure Health Canada and Health Minister Jean-Yves Duclos to take action in protecting the health and well-being of Canadian women and their preborn children.

With your help, we can pressure Health Canada to act now to protect maternal and infant health and prevent further tragedies.

Newsletter Signup

Stay in the loop with exclusive news, stories, and insights—delivered straight to your inbox. No fluff, just real content that matters. Sign up today!

Written By

We, as humans are guaranteed certain things in life: stressors, taxes, bills and death are the first thoughts that pop to mind. It is not uncommon that many people find a hard time dealing with these daily life stressors, and at times will find themselves losing control over their lives. Simone Jennifer Smith’s great passion is using the gifts that have been given to her, to help educate her clients on how to live meaningful lives. The Hear to Help Team consists of powerfully motivated individuals, who like Simone, see that there is a need in this world; a need for real connection. As the founder and Director of Hear 2 Help, Simone leads a team that goes out into the community day to day, servicing families with their educational, legal and mental health needs.Her dedication shows in her Toronto Caribbean newspaper articles, and in her role as a host on the TCN TV Network.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Canadian politics for dummies

Junior Contributors

Unreal milk is just what it is-unreal

News & Views

What do parents do when they see that their children are being harmed by a system that is supposed to help?

News & Views

Six inventions that have not be credited to African inventors: CACD’s commitment to ongoing education and systemic change

Business

Newsletter Signup

Stay in the loop with exclusive news, stories, and insights—delivered straight to your inbox. No fluff, just real content that matters. Sign up today!

Legal Disclaimer: The Toronto Caribbean Newspaper, its officers, and employees will not be held responsible for any loss, damages, or expenses resulting from advertisements, including, without limitation, claims or suits regarding liability, violation of privacy rights, copyright infringement, or plagiarism. Content Disclaimer: The statements, opinions, and viewpoints expressed by the writers are their own and do not necessarily reflect the opinions or views of Toronto Caribbean News Inc. Toronto Caribbean News Inc. assumes no responsibility or liability for claims, statements, opinions, or views, written or reported by its contributing writers, including product or service information that is advertised. Copyright © 2025 Toronto Caribbean News Inc.

Connect
Newsletter Signup

Stay in the loop with exclusive news, stories, and insights—delivered straight to your inbox. No fluff, just real content that matters. Sign up today!